News | October 06, 2010

Arteriotomy Devices Reasonable, But More Research Needed


October 6, 2010 – A new statement from the American Heart Association says arteriotomy closure devices are reasonable to use, but their benefits should be weighed against the risk of complications.

Arteriotomy, the process of creating a hole in an access artery through which instruments are inserted, is the first step in procedures such as angiography or percutaneous coronary intervention (PCI). Closing up the artery is a concern due to possible bleeding complications.

Arteriotomy closure is typically done with manual compression, but more devices are entering the market to offer potential improvements over manual closure. The statement is published in Circulation: Journal of the American Heart Association.

The statement authors conclude that the devices are reasonable to use - and they offer recommendations for their use based on available evidence - but their benefits should be weighed against the risk of complications in patients. Patient-specific factors such as age, gender and disease severity should be considered before using an arteriotomy closure device.

The statement also includes recommendations for future trials and end points needed to inform clinical practice.

In the United States, 1.3 million PCI procedures were performed in 2006, the most recent year for which data is available.

For more information: www.heart.org


Related Content

News | Hemostasis Management

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

Home October 27, 2021
Home
News | Hemostasis Management

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Home
News | Hemostasis Management

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

Home February 08, 2021
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
Technology | Hemostasis Management

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available ...

Home February 01, 2019
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to ...

Home August 24, 2016
Home
News | Hemostasis Management

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...

Home January 06, 2016
Home
Subscribe Now